Heterogeneity of FDG-PET response to GSK2118436, an inhibitor of oncogenic mutant BRAF-kinase in BRAF-mutant metastatic melanoma

M. S. Carlino, C. A. Saunders, V. Gebski, A. M. Menzies, B. Ma, P. F. Lebowitz, R. Kefford, G. V. Long

Research output: Contribution to journalMeeting abstractpeer-review

Original languageEnglish
Pages (from-to)8539
Number of pages1
JournalJournal of Clinical Oncology
Issue number15
Publication statusPublished - 20 May 2011

Cite this